Skip to main content
. 2023 Apr 14;31(7):2077–2088. doi: 10.1016/j.ymthe.2023.04.006

Figure 4.

Figure 4

Cumulative survival (%) of OBP-301-injected patients

Kaplan-Meier curve of surviving patients. (A) Overall survival (OS) of all patients who completed the treatment protocols. The overall median OS was 26.00 weeks. (B) Survival curve according to groups. The median OS from the Kaplan-Meier analysis was 40.86 weeks (cohort 2), 12.86 weeks (cohort 4), and 23.00 weeks (cohort 5). (C) Survival curve according to the local response. SD, 102.6 weeks; PD, 14.1 weeks.